Saskatoon, Saskatchewan, Canada
March 17, 2010

Colin Bletsky has been appointed to Global Business Development Director for Novozymes Biologicals BioAg Group. Colin has over thirteen years of experience in agriculture, and for the last nine years has taken progressively more senior roles in the crop protection industry. Colin will oversee the identification, prioritization, acquisition, and development of new opportunities for Novozymes’ BioAg Group on a global basis. Novozymes Biologicals is proud to have Colin onboard.

The BioAg Group of Novozymes Biologicals manufactures and sells the inoculants JumpStart®, TagTeam®, and N-Prove®, in addition to biocontrol agents and yield enhancers.

Novozymes Biologicals BioAg Group is currently developing and marketing products in 30 countries around the globe, helping the world’s farmers produce more, and better food, feed, fuel, and
fibre, while minimizing the environmental footprint of production agriculture. Find out more about Novozymes Biologicals BioAg Group at www.bioag.novozymes.com.

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers’ business, and the use of our planet’s resources.
With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for
tomorrow’s ever-changing marketplace.
Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces.
Our 5,000+ employees working in research, production, and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on NASDAQ OMX Copenhagen A/S. Read more at www.novozymes.com

Website: https://www.novonesis.com/en

Published: March 17, 2010